![Duane Dorn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Duane Dorn
Director of Finance/CFO at CDx Diagnostics, Inc.
Duane Dorn active positions
Companies | Position | Start | End |
---|---|---|---|
CDx Diagnostics, Inc.
![]() CDx Diagnostics, Inc. Medical SpecialtiesHealth Technology CDx Diagnostics, Inc. develops and delivers instruments for detection and prevention of cancers. It is a specialized pathology lab that utilizes patented CDx Technology to analyze a disaggregated tissue specimen of the entire thickness of the suspect epithelium. The firm involves in detection and prevention of cancers of the esophagus, oral cavity, pharynx, and larynx. CDx Diagnostics provides clinicians with unique tools to enhance their detection of precancerous change through complete epithelial sampling combined with computer-assisted morphological and molecular laboratory analysis. The company was founded by Mark Rutenberg and Drore Eisen in 1997 and is headquarters in Suffern, NY. | Chief Operating Officer | 31/03/2020 | - |
Director of Finance/CFO | - | - |
Career history of Duane Dorn
Training of Duane Dorn
St. Bonaventure University | Masters Business Admin |
Statistics
International
United States | 3 |
Operational
Chief Operating Officer | 1 |
Director of Finance/CFO | 1 |
Masters Business Admin | 1 |
Sectoral
Health Technology | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
CDx Diagnostics, Inc.
![]() CDx Diagnostics, Inc. Medical SpecialtiesHealth Technology CDx Diagnostics, Inc. develops and delivers instruments for detection and prevention of cancers. It is a specialized pathology lab that utilizes patented CDx Technology to analyze a disaggregated tissue specimen of the entire thickness of the suspect epithelium. The firm involves in detection and prevention of cancers of the esophagus, oral cavity, pharynx, and larynx. CDx Diagnostics provides clinicians with unique tools to enhance their detection of precancerous change through complete epithelial sampling combined with computer-assisted morphological and molecular laboratory analysis. The company was founded by Mark Rutenberg and Drore Eisen in 1997 and is headquarters in Suffern, NY. | Health Technology |
- Stock Market
- Insiders
- Duane Dorn
- Experience